Sandu Pharmaceuticals Ltd.
| BSE: 524703 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE751D01014 |
| BSE 00:00 | 30 Jun | 64.40 |
0.85 (1.34%) |
OPEN
63.55 |
HIGH
65.90 |
LOW
62.55 |
| NSE 05:30 | 01 Jan | Sandu Pharmaceuticals Ltd |
| OPEN | 63.55 |
| PREVIOUS CLOSE | 63.55 |
| VOLUME | 1897 |
| 52-Week high | 86.00 |
| 52-Week low | 43.35 |
| P/E | 35.78 |
| Mkt Cap.(Rs cr) | 57 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Sandu Pharmaceuticals Ltd. (SANDUPHARMA) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 513.80 | -1.05 | -0.20 | 15823.68 |
| Cipla | 915.20 | -30.40 | -3.21 | 13900.58 |
| Dr Reddy's Labs | 4399.90 | 36.60 | 0.84 | 13349.10 |
| Sun Pharma.Inds. | 830.80 | -7.35 | -0.88 | 12803.21 |
| Lupin | 611.40 | -8.80 | -1.42 | 11055.93 |
| Apollo Hospitals | 3679.85 | -35.35 | -0.95 | 9153.00 |
| Zydus Lifesci. | 356.75 | 0.70 | 0.20 | 7790.40 |
| Glenmark Pharma. | 387.00 | -2.00 | -0.51 | 7567.93 |
| Alkem Lab | 3001.05 | 28.20 | 0.95 | 7219.68 |
| Divi's Lab. | 3631.00 | 46.50 | 1.30 | 6798.61 |
| Torrent Pharma. | 2859.40 | 19.10 | 0.67 | 6450.83 |
| Ipca Labs. | 891.95 | -4.40 | -0.49 | 5114.11 |
| Alembic Pharma | 730.95 | -7.90 | -1.07 | 5051.44 |
| Laurus Labs | 464.50 | -2.10 | -0.45 | 4707.04 |
| Abbott India | 18787.35 | -176.95 | -0.93 | 4310.02 |
| Gland Pharma | 2701.85 | 49.60 | 1.87 | 3462.88 |
| Glaxosmi. Pharma | 1499.70 | 1.80 | 0.12 | 3217.51 |
| Granules India | 272.80 | -4.00 | -1.45 | 3134.98 |
| Sanofi India | 6436.40 | 15.90 | 0.25 | 2956.60 |
| Ajanta Pharma | 1234.80 | 11.95 | 0.98 | 2718.59 |
Quick Links for Sandu Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
